Phenotypic and Molecular Characteristics of Carbapenem-Non-Susceptible Enterobacteriaceae from a Teaching Hospital in Wenzhou, Southern China

Japanese Journal of Infectious Diseases

Volumn 66, Issue 2, 2013, Pages 96-102

  Zhou, Tieli ^a   Zhang, Xiaolei ^b   Guo, Meiyan ^a   Ye, Jianbo ^b   Lu, Yamin ^b   Bao, Qiyu ^b   Chi, Wenjie ^b  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEMASE; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; PORIN; SULPERAZON;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CLONE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE SEQUENCE; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PULSED FIELD GEL ELECTROPHORESIS; SERRATIA MARCESCENS; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHINA; CONJUGATION, GENETIC; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE TRANSFER, HORIZONTAL; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION;

EID: 84875325065     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.96     Document Type: Article

References (36)

1. Ko, K.S., Lee, M.Y., Song, J.H., et al. (2008): Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis., 61, 453-459.
2. Potz, N.A., Hope, R., Warner, M., et al. (2006): Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J. Antimicrob. Chemother., 58, 320-326.
3. Schlesinger, J., Navon-Venezia, S., Chmelnitsky, I., et al. (2005): Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother., 49, 1150-1156.
4. Cullik, A., Pfeifer, Y., Prager, R., et al. (2010): A novel IS26 structure surrounds blaCTX-M genes in different plasmids from German clinical Escherichia coli isolates. J. Med. Microbiol., 59, 580-587.
5. Kaczmarek, F.M., Dib-Hajj, F., Shang, W., et al. (2006): Highlevel carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob. Agents Chemother., 50, 3396-3406.
6. Oteo, J., Delgado-Iribarren, A., Vega, D., et al. (2008): Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents, 32, 534-537.
7. Vatopoulos, A. (2008): High rates of metallo-beta-lactamaseproducing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro Surveillance, 13.
8. Yigit, H., Queenan, A.M., Anderson, G.J., et al. (2001): Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother., 45, 1151-1161.
9. Cai, J.C., Zhou, H.W., Zhang, R., et al. (2008): Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob. Agents Chemother., 52, 2014-2018.
10. Wei, Z.Q., Du, X.X., Yu, Y.S., et al. (2007): Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob. Agents Chemother., 51, 763-765.
11. Clinical and Laboratory Standards Institute (2011): Performance Standards for Antimicrobial Susceptibility Testing: 21st Informational Supplement. M100-S21. CLSI, Wayne, Pa.
12. Hossain, A., Ferraro, M.J., Pino, R.M., et al. (2004): Plasmidmediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob. Agents Chemother., 48, 4438-4440.
13. Carrer, A., Poirel, L., Pitout, J.D., et al. (2008): Occurrence of an SME-2-producing Serratia marcescens isolate in Canada. Int. J. Antimicrob. Agents, 31, 181-182.
14. Pasteran, F., Mendez, T., Guerriero, L., et al. (2002): Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J. Clin. Microbiol., 47, 1631-1639.
15. Kwon, N.Y., Kim, J.D., Pai, H.J. (2002): The resistance mechanisms of β-lactam antimicrobials in clinical isolates of Acinetobacter baumannii. Korean J. Intern. Med., 17, 94-99.
16. Chen, L.R., Zhou, H.W., Cai, J.C., et al. (2009): Detection of plasmid-mediated IMP-1 metallo-beta-lactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate. J. Zhejiang Univ. Sci. B., 10, 348-354.
17. Lee, K., Yong, D., Choi, Y.S., et al. (2007): Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int. J. Antimicrob. Agents, 29, 201-206.
18. Grobner, S., Linke, D., Schutz, W., et al. (2009): Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J. Med. Microbiol., 58, 912-922.
19. Lee, K., Yum, J.H., Yong, D., et al. (2005): Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother., 49, 4485-4491.
20. Sader, H.S., Reis, A.O., Silbert, S., et al. (2005): IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin. Microbiol. Infect., 11, 73-76.
21. Poirel, L., Heritier, C., Tolun, V., et al. (2004): Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother., 48, 15-22.
22. Pérez-Pérez, F.J. and Hanson, N.D. (2002): Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol., 40, 2153-2162.
23. Yu, Y., Ji, S., Chen, Y., et al. (2007): Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J. Infect., 54, 53-57.
24. Yuan, M., Aucken, H., Hall, L.M., et al. (1998): Epidemiological typing of Klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J. Antimicrob. Chemother., 41, 527-539.
25. Ligozzi, M., Fontana, R., Aldegheri, M., et al. (2010): Comparative evaluation of an automated repetitive-sequence-based PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak. J. Clin. Microbiol., 48, 1690-1695.
26. Tenover, F.C., Arbeit, R.D., Goering, R.V., et al. (1995): Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239.
27. Hernandez-Alles, S., Alberti, S., Alvarez, D., et al. (1999): Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology, 145, 673-679.
28. Zhang, R., Yang, L., Cai, J.C., et al. (2008): High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J. Med. Microbiol., 57, 332-337.
29. Mataseje, L.F., Bryce, E., Roscoe, D., et al. (2012): Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J. Antimicrob. Chemother., 67, 1359-1367.
30. Yang, Q., Wang, H., Sun, H., et al. (2010): Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob. Agents Chemother., 54, 573-577.
31. Hirsch, E.B. and Tam, V.H. (2010): Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother., 65, 1119-1125.
32. Giakkoupi, P., Pappa, O., Polemis, M., et al. (2009): Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob. Agents Chemother., 53, 4048-4050.
33. Shin, S.Y., Bae, I.K., Kim, J., et al. (2012): Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. J. Med. Microbiol., 61, 239-245.
34. Walsh, T.R. (2010): Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents, 36, 8-14.
35. Doumith, M., Ellington, M.J., Livermore, D.M., et al. (2009): Molecular mechanisms disrupting porin expression in ertapenemresistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother., 63, 659-667.
36. Ko, K.S., Yeom, J.S., Lee, M.Y., et al. (2008): Clonal dissemination of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolates in a Korean hospital. J. Korean Med. Sci., 23, 53-60.